Design, synthesis, and biological evaluation of new 2-(4-(methylsulfonyl)phenyl)-N-phenylimidazo[1,2-a]pyridin-3-amine as selective COX-2 inhibitors
作者:Mahsa Azami Movahed、Fatemeh Khadem Abbasi、Mahsa Rajabi、Niusha Abedi、Nima Naderi、Bahram Daraei、Afshin Zarghi
DOI:10.1007/s00044-023-03041-x
日期:——
effects, such as gastrointestinal ulcers, limit the use of these medications. In recent years, selective COX-2 inhibitors with a lower incidence of adverse effects attained an important position in medicinal chemistry. In order to introduce some new potent COX-2 inhibitors, a new series of 2-(4-(methylsulfonyl)phenyl)-N-phenylimidazo[1,2-a]pyridin-3-amines was designed, synthesized, and evaluated. The docking
环氧合酶 (COX) 在将花生四烯酸转化为炎症介质中发挥作用,可被非甾体类抗炎药 (NSAID) 抑制。虽然有效的非甾体抗炎药可用于治疗疼痛、发烧和炎症,但一些副作用(如胃肠道溃疡)限制了这些药物的使用。近年来,不良反应发生率较低的选择性COX-2抑制剂在药物化学中占有重要地位。为了引入一些新的强效 COX-2 抑制剂,一个新系列的 2-(4-(methylsulfonyl)phenyl)-N- phenylimidazo [1,2- a] pyridin-3-amines 被设计、合成和评估。AutoDock Vina 进行的对接研究表明,对接分子以及晶体配体位于 COX-2 活性位点,SO 2Me 药效团被插入 COX-2 的次级口袋并与活性位点形成氢键。设计的化合物通过两步反应合成。第一步,通过苯胺衍生物与α-溴-4-(甲基磺酰基)苯乙酮反应得到不同的1-(4-(甲基磺酰基)苯基)-